Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Microscale Bioreactor

By R&D Editors | November 9, 2009

ambrThe Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, is exclusively previewing its Advanced Microscale BioReactor (ambr) technology on Booth 914 at the Bioprocess International Conference in Raleigh, USA.
  
ambr is an advanced microscale bioreactor that mimics the physical characteristics of classical bioreactors at microscale (10-15ml) using disposable reactor cartridges. The system will enable rapid evaluation of multiple bioreactor cultures at microscale to select improved cell lines faster with significant savings on materials and labour. The system is being designed in collaboration with a number of independent partners including: leading developers of therapeutic antibodies, major biologic contract manufacturing organisations and an innovative academic bioprocess engineering department.

The first generation ambr workstation automates the operation of 24 low-cost, disposable plastic bioreactors with a 10-15ml working volume, providing individual closed loop control of dissolved O2 and pH and a supply of CO2, N2, O2. The bioreactors are arranged as two sets of 12, each supplied with independent stirring and temperature control. The system automates culture set-up and inoculation; the addition of alkalis and feeds, as well as media sampling during the run for cell count and other analysis, thus reducing the number of manual processing steps and the possibility of cross contamination.  Additionally, because ambr uses many disposable components, the need for cleaning and sterilising is significantly reduced further saving users’ time.
 
Most cell line developers would like to select clones under conditions that are as close as possible to those in a full size bioreactor but cost and time constraints mean that this is not practical. This has lead to people looking for microscale tube or plate-based systems but until now, none of these included all the common physical characteristics of bioreactors such as impellers, gas sparging, and closed loop control of pH and DO.  By mimicking conditions at larger scale, ambr has the potential to enable more effective development strategies, cost reduction and significant improvements in product quality.

The Automation Partnership 

Related Articles Read More >

2025 R&D layoffs tracker: 83,543 and counting
Health-related innovation in Morocco highlighted by resident inventor patenting activity
ARPA-H funds $29M Ginkgo-led project to reshore pharma supply chains using wheat germ tech
DNA microscope offers new 3D view of organisms from the inside out
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE